Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 7870815, 5 pages
http://dx.doi.org/10.1155/2016/7870815
Research Article

Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?

1Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
2Department of Surgery, Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University, Nonthaburi, Thailand
3Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
4Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
5Division of Medical Oncology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Received 24 June 2016; Accepted 1 September 2016

Academic Editor: Alessandro Passardi

Copyright © 2016 Kittinut Timudom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Khuhaprema and P. Srivatanakul, “Colon and rectum cancer in Thailand: an overview,” Japanese Journal of Clinical Oncology, vol. 38, no. 4, pp. 237–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1731–1740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mohiuddin, K. Winter, E. Mitchell et al., “Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: radiation Therapy Oncology Group Trial 0012,” Journal of Clinical Oncology, vol. 24, no. 4, pp. 650–655, 2006. View at Publisher · View at Google Scholar
  4. Y. Francois, C. J. Nemoz, J. Baulieux et al., “Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial,” Journal of Clinical Oncology, vol. 17, no. 8, pp. 2396–2402, 1999. View at Google Scholar · View at Scopus
  5. L. F. de Campos-Lobato, D. P. Geisler, A. da Luz Moreira, L. Stocchi, D. Dietz, and M. F. Kalady, “Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery,” Journal of Gastrointestinal Surgery, vol. 15, no. 3, pp. 444–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Sloothaak, D. E. Geijsen, N. J. van Leersum et al., “Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer,” The British Journal of Surgery, vol. 100, no. 7, pp. 933–939, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Tulchinsky, E. Shmueli, A. Figer, J. M. Klausner, and M. Rabau, “An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer,” Annals of Surgical Oncology, vol. 15, no. 10, pp. 2661–2667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. H. Jeong, H. B. Lee, H. Hur, B. S. Min, S. H. Baik, and N. K. Kim, “Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer,” Journal of the Korean Surgical Society, vol. 84, no. 6, pp. 338–345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-L. Tran, S. Udani, A. Holt, T. Arnell, R. Kumar, and M. J. Stamos, “Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer,” American Journal of Surgery, vol. 192, no. 6, pp. 873–877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Habr-Gama, R. O. Perez, G. P. São Julião, I. Proscurshim, and J. Gama-Rodrigues, “Nonoperative approaches to rectal cancer: a critical evaluation,” Seminars in Radiation Oncology, vol. 21, no. 3, pp. 234–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Garcia-Aguilar, O. S. Chow, D. D. Smith et al., “Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial,” The Lancet Oncology, vol. 16, no. 8, pp. 957–966, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. G. Moore, A. E. Gittleman, B. D. Minsky et al., “Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection,” Diseases of the Colon and Rectum, vol. 47, no. 3, pp. 279–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. K. Wong, V. Tandan, S. De Silva, and A. Figueredo, “Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD002102, 2007. View at Google Scholar · View at Scopus
  14. D. E. Stein, N. N. Mahmoud, P. R. Anné et al., “Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma,” Diseases of the Colon and Rectum, vol. 46, no. 4, pp. 448–453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Kalady, L. F. de Campos-Lobato, L. Stocchi et al., “Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer,” Annals of Surgery, vol. 250, no. 4, pp. 582–588, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. P. Probst, A. Z. Becerra, C. T. Aquina et al., “Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation,” Journal of the American College of Surgeons, vol. 221, no. 2, pp. 430–440, 2015. View at Publisher · View at Google Scholar · View at Scopus